RVMD
Revolution Medicines Inc
206.60$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 175.7% | 160.9% | 163.8% | 183.6% | 227.4% | 237.8% | 328.4% | 275.4% | 422.9% | 403.3% | 528.1% | 4,221.0% | 567.5% | 745.4% | 669.2% | 2,069.6% | 431.4% | 983.0% | 199.8% | – | 18,407.1% | – | – | – | 71.9% | – | – | – | – | – | – | – | |
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | -71.9% | – | – | – | – | – | – | – | |
| – | 175.7% | 160.9% | 163.8% | 183.6% | 227.4% | 237.8% | 328.4% | 275.4% | 422.9% | 403.3% | 528.1% | 4,221.0% | 567.5% | 745.4% | 669.2% | 2,069.6% | 431.4% | 983.0% | 2,562.3% | – | 20,010.9% | – | – | – | 71.9% | – | – | – | – | – | – | – | |
| 56.8% | 37.1% | 18.4% | 22.2% | 24.8% | 34.4% | 44.8% | 50.8% | 42.2% | 66.6% | 65.8% | 83.9% | 707.6% | 91.9% | 119.3% | 111.9% | 310.9% | 71.2% | 188.5% | 382.8% | – | 4,345.6% | – | – | – | 10.8% | – | – | – | – | – | – | – | |
| – | 212.8% | 179.3% | 186.0% | 208.4% | 261.8% | 282.6% | 379.1% | 317.6% | 489.4% | 469.1% | 612.0% | 4,928.6% | 659.3% | 864.7% | 781.1% | 2,380.5% | 502.5% | 1,171.5% | 2,945.1% | – | 24,356.5% | – | – | – | 82.7% | – | – | – | – | – | – | – | |
| -291.9% | -112.8% | -79.3% | -86.0% | -108.4% | -161.8% | -182.6% | -279.1% | -217.6% | -389.4% | -369.1% | -512.0% | -4,828.6% | -559.3% | -764.7% | -681.1% | -2,280.5% | -402.5% | -1,071.5% | -2,845.1% | – | -24,256.5% | – | – | – | -82.7% | – | – | – | – | – | – | – | |
| – | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 0.2% | 0.1% | 0.0% | 0.0% | 0.3% | 4.0% | 9.5% | 86.6% | 20.9% | 136.8% | – | – | 1,251.9% | – | – | – | – | – | – | – | – | – | – | – | |
| -310.1% | -109.6% | -76.9% | -82.4% | -102.5% | -156.9% | -174.9% | -272.0% | -215.0% | -386.7% | -367.0% | -509.3% | -4,808.4% | -556.8% | -760.7% | -671.6% | -2,193.9% | -369.4% | -970.9% | -2,570.6% | – | -21,724.3% | – | – | – | -74.7% | – | – | – | – | – | – | – | |
| – | 3.5% | 2.5% | 3.8% | 6.1% | -36.2% | -5.8% | -0.6% | 2.7% | 4.1% | 2.3% | 2.7% | 20.3% | -19.3% | -4.0% | -9.5% | -8.8% | -0.8% | -136.8% | -46.4% | – | 46.2% | – | – | – | -0.3% | – | – | – | – | – | – | – | |
| -310.1% | -109.6% | -76.9% | -82.4% | -102.5% | -120.7% | -169.1% | -271.5% | -215.0% | -390.9% | -367.0% | -509.3% | -4,808.4% | -556.8% | -760.7% | -671.6% | -2,185.0% | -368.6% | -970.9% | -2,570.6% | – | -21,770.5% | – | – | – | -74.4% | – | – | – | – | – | – | – | |
| – | -102.6% | -70.7% | -75.6% | -95.3% | -149.6% | -161.3% | -255.2% | -202.0% | -367.1% | -350.3% | -488.1% | -4,649.3% | -535.0% | -730.5% | -646.0% | -2,121.4% | -352.5% | -934.8% | -2,524.2% | – | -17,456.6% | – | – | – | -73.4% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.